XERS icon

Xeris Biopharma Holdings
XERS

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$9.5
57% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Brandon Folkes
50% 1-yr XERS win rate
2 Mar ‘26 2 days ago
Barclays
Barclays
Glen Santangelo
0% 1-yr XERS win rate
9 Dec ‘25 2 months ago